Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Pantheon International director raises stake

(Sharecast News) - Pantheon International revealed on Thursday that non-executive director John Burgess had acquired 166,038 ordinary shares in the FTSE 250-listed investment trust. Burgess, who made the purchase via his interest in The November 1990 Trust, snapped up the shares at an average price of 324.65p each, for a total value of £539,047.48.

As of 1620 BST, Pantheon shares were flat at 323.50p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Pantheon International (PIN) Director name: Burgess ,John Amount purchased: 166,038 @ 324.65p Value: £539,047.48

Staffline Group (STAF) Director name: Spain,Thomas Amount purchased: 101,266 @ 35.55p Value: £36,000.06

Hydrogen Utopia International (HUI) Director name: White,Howard Amount purchased: 500,000 @ 4.88p Value: £24,400.00

Seed Innovations Limited (SEED) Director name: Jersey,Lance De Amount purchased: 1,000,000 @ 1.45p Value: £14,500.00

Top Director Sells

Bloomsbury Publishing (BMY) Director name: Newton,Nigel Amount sold: 58,378 @ 713.30p Value: £416,410.27

Bloomsbury Publishing (BMY) Director name: Scott-Bayfield,Penny Amount sold: 38,085 @ 713.30p Value: £271,660.30

Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 101,266 @ 35.55p Value: £36,000.06

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 600 @ $4.30 Value: $2,127.48

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 400 @ $4.26 Value: $1,403.48

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 400 @ $4.23 Value: $1,395.23

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 301 @ $4.27 Value: $1,059.84

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 296 @ $4.31 Value: $1,052.00

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 300 @ $4.23 Value: $1,046.43

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 206 @ $4.23 Value: $718.55

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 200 @ $4.35 Value: $717.41

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 152 @ $4.28 Value: $536.46

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 87 @ $4.29 Value: $307.77

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 58 @ $4.26 Value: $203.98

Share this article

Related Sharecast Articles

Director dealings: Moneysupermarket director PCA snaps up shares
(Sharecast News) - Moneysupermarket.com revealed on Wednesday that non-executive director Rakesh Sharma's wife, Kathleen Sharma, had acquired 9,253 ordinary shares in the FTSE 250-listed price comparison website operator.
Director dealings: Kazera Global chairman raises stake
(Sharecast News) - Kazera Global revealed on Tuesday that chairman John Wardle had acquired 9.5m ordinary shares in the AIM-listed investment company.
Director dealings: Bluejay Mining non executive director ups stake
(Sharecast News) - Bluejay Mining revealed on Friday that non-executive director Roderick McIllree had acquired 7.5m ordinary shares in the AIM-listed exploration and development company.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.